Capricor Therapeutics
CAPR
#7318
Rank
NZ$1.01 B
Marketcap
NZ$17.48
Share price
9.44%
Change (1 day)
76.89%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2023 (TTM): NZ-$1.92

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$4.35. In 2022 the company made an earnings per share (EPS) of NZ-$2.09 a decrease over its 2021 EPS that were of NZ-$1.54.

EPS history for Capricor Therapeutics from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$1.92-8.43%
2022NZ-$2.0935.63%
2021NZ-$1.54-7.45%
2020NZ-$1.67-55.45%
2019NZ-$3.74-59.81%
2018NZ-$9.32-1850%
2017NZ$0.53-102.94%
2016NZ-$18.1025.93%
2015NZ-$14.3755.77%
2014NZ-$9.23-39.53%
2013NZ-$15.26-64.78%
2012NZ-$43.32-62.44%
2011NZ-$115.34-31.58%
2010NZ-$168.57-38.71%
2009NZ-$275.03-43.64%
2008NZ-$487.96-5.17%
2007NZ-$514.58427.27%
2006NZ-$97.59340.33%
2005NZ-$22.16
2004N/A
2003N/A
2002N/A
2001N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.86-372.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$12.51-387.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ-$12.81 194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.72 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$13.40 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$51.97 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA